261 related articles for article (PubMed ID: 14622664)
1. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.
Zheng S; He L; Yang X; Li X; Yang Z
Medicine (Baltimore); 2017 Mar; 96(11):e6354. PubMed ID: 28296770
[TBL] [Abstract][Full Text] [Related]
4. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
6. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
Gestin Y; Vainio A; Pégurier AM
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
[TBL] [Abstract][Full Text] [Related]
9. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
11. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
Kumar K; Kelly M; Pirlot T
Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
[TBL] [Abstract][Full Text] [Related]
12. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
13. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
14. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
Mitchell A; McGhie J; Owen M; McGinn G
Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
[TBL] [Abstract][Full Text] [Related]
15. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
16. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
[TBL] [Abstract][Full Text] [Related]
17. The effective duration of analgesia after intrathecal morphine in patients without additional opioid analgesia: a randomized double-blind multicentre study on orthopaedic patients.
Gehling MH; Luesebrink T; Kulka PJ; Tryba M
Eur J Anaesthesiol; 2009 Aug; 26(8):683-8. PubMed ID: 19307970
[TBL] [Abstract][Full Text] [Related]
18. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine.
Sabatowski R; Kasper SM; Radbruch L
J Pain Symptom Manage; 2002 Jan; 23(1):3-5. PubMed ID: 11779660
[No Abstract] [Full Text] [Related]
19. A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement.
Grace D; Fee JP
Anesth Analg; 1996 Nov; 83(5):1055-9. PubMed ID: 8895285
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of intrathecal morphine after posterior lumbar interbody fusion surgery: a prospective, double-blind, randomized study.
Ziegeler S; Fritsch E; Bauer C; Mencke T; Müller BI; Soltesz S; Silomon M
Spine (Phila Pa 1976); 2008 Oct; 33(22):2379-86. PubMed ID: 18923312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
